IL SB1802

Requires government programs and health insurers offering prescription drug coverage to list abuse-deterrent opioid analgesic drugs as preferred drugs on formularies and preferred drug lists effective upon passage.

Prohibits cost sharing for abuse-deterrent opioid drugs that exceeds the lowest cost sharing level applied to other prescription drugs.

Prohibits insurers from requiring patients to first use non-abuse-deterrent opioid products before covering abuse-deterrent opioid products.

Prohibits prior authorization requirements and utilization reviews from mandating trial use of non-abuse-deterrent opioids before accessing abuse-deterrent versions, though insurers may apply prior authorization equally to both types.

Applies requirements to state employee health plans, county and municipal self-insured plans, school employee plans, health maintenance organizations, limited health service organizations, voluntary health service plans, and Medicaid.